EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK/MAPK pathway.
about
Epstein-Barr virus and the origin of Hodgkin lymphomaRoles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implicationsEpigenetic Impact on EBV Associated B-Cell LymphomagenesisEpstein-Barr virus latent genesIdentification of protein kinase inhibitors with a selective negative effect on the viability of Epstein-Barr virus infected B cell linesEpstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2AA shared gene expression signature in mouse models of EBV-associated and non-EBV-associated Burkitt lymphomaSignalling thresholds and negative B-cell selection in acute lymphoblastic leukaemiaEpstein-Barr virus Latent Membrane Protein 2A (LMP2A)-mediated changes in Fas expression and Fas-dependent apoptosis: Role of Lyn/Syk activation.Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo.Integrated analyses of genome-wide DNA occupancy and expression profiling identify key genes and pathways involved in cellular transformation by a Marek's disease virus oncoprotein, Meq.Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis.How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?Ras orchestrates exit from the cell cycle and light-chain recombination during early B cell development.Manipulation of the host cell membrane by human γ-herpesviruses EBV and KSHV for pathogenesis.Epstein-Barr virus latent membrane protein 2A contributes to anoikis resistance through ERK activation.Epstein-Barr virus LMP2A accelerates MYC-induced lymphomagenesis.A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infectionSpleen Tyrosine Kinase Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of Epstein-Barr Virus-Associated LymphomaEpstein-Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis
P2860
Q26998999-AC18D374-7376-473A-9A96-7E5D681377B7Q27009016-5A2A02F6-71B6-406C-9B3B-21004A37BA2BQ28068361-E67D64A3-6A70-4974-A8D4-570FDC454711Q28082701-D550D494-7C9E-45FC-A820-15C251BC9330Q31159325-2997CE4E-EE89-43A3-A0A1-6AC10C76C348Q33794029-85479E82-1DF2-416C-A5F1-FD480C450CD2Q35631310-BE2976C3-CA2F-4EA6-B318-058D9DBE7598Q35637452-F1E48655-A9CB-4C50-8320-234EA8B603CBQ36199894-C1FA4E95-9244-4880-8C18-A1D92F15C58AQ37039112-D3C66025-6B12-443D-9802-BC5A14381248Q37123241-DCBE1AFA-3021-4C90-AD0C-EE2D2B3907D8Q37394390-00FDE06C-4532-4643-AE69-5AF94BF057C6Q37563700-B6396191-76A6-4ADD-B09B-6DCE352B353EQ38350712-4049142E-A73D-4DFC-B961-703C47F67AB0Q38953504-88343D13-3AAC-49EB-954E-D00000B79F18Q39148562-777D5F9B-7AF3-40D2-9E7C-5A802581C005Q39742944-F7E0B137-3B3D-4D5C-B0C0-77D83E9F6C64Q56355742-1D4F1231-4340-49FB-9615-7D1F948F9BFFQ58721423-8870BC52-B6D7-4333-90A9-8D36ED4BB474Q58803477-FCDD27FA-D53D-4704-A3F3-A3875166F18A
P2860
EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK/MAPK pathway.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
EBV LMP2A provides a surrogate ...... ation of the ERK/MAPK pathway.
@ast
EBV LMP2A provides a surrogate ...... ation of the ERK/MAPK pathway.
@en
type
label
EBV LMP2A provides a surrogate ...... ation of the ERK/MAPK pathway.
@ast
EBV LMP2A provides a surrogate ...... ation of the ERK/MAPK pathway.
@en
prefLabel
EBV LMP2A provides a surrogate ...... ation of the ERK/MAPK pathway.
@ast
EBV LMP2A provides a surrogate ...... ation of the ERK/MAPK pathway.
@en
P2860
P356
P1476
EBV LMP2A provides a surrogate ...... ation of the ERK/MAPK pathway.
@en
P2093
Leah J Anderson
Richard Longnecker
P2860
P304
P356
10.1099/VIR.0.2008/001461-0
P407
P577
2008-07-01T00:00:00Z